About this Research Topic
In recent years, cancer drug development has witnessed significant advancements driven by breakthroughs in understanding the molecular and genetic basis of cancer. These advancements have led to the emergence of targeted therapies, immunotherapies, and precision medicine approaches. However, challenges such as drug resistance and tumor heterogeneity persist, necessitating ongoing research and collaboration for improved cancer treatments.
With cancer being a complex and heterogeneous disease, the need for innovative therapeutic approaches is ever more crucial. This collection celebrates the success stories achieved in drug discovery for cancer treatment while providing insights into the open challenges that researchers continue to face.
By highlighting the progress made and exploring future directions, this collection aims to inspire further innovation and collaboration in the quest for more effective and personalized cancer therapies.
Topics will include but are not limited to:
1. Targeted Therapies: Successes and Lessons Learned
2. Immunotherapy Breakthroughs
3. Emerging Technologies: the promise of precision medicine and the challenges of implementing new technologies on a larger scale and integrating them into clinical practice.
4. Combined therapy: old and new therapeutical approaches combined to obtain improved and synergic effects.
Topic Editor Tashinga E Bapiro is employed by AstraZeneca. All other Topic Editors declare no competing interests with regards to the Research Topic subject.
With cancer being a complex and heterogeneous disease, the need for innovative therapeutic approaches is ever more crucial. This collection celebrates the success stories achieved in drug discovery for cancer treatment while providing insights into the open challenges that researchers continue to face.
By highlighting the progress made and exploring future directions, this collection aims to inspire further innovation and collaboration in the quest for more effective and personalized cancer therapies.
Topics will include but are not limited to:
1. Targeted Therapies: Successes and Lessons Learned
2. Immunotherapy Breakthroughs
3. Emerging Technologies: the promise of precision medicine and the challenges of implementing new technologies on a larger scale and integrating them into clinical practice.
4. Combined therapy: old and new therapeutical approaches combined to obtain improved and synergic effects.
Topic Editor Tashinga E Bapiro is employed by AstraZeneca. All other Topic Editors declare no competing interests with regards to the Research Topic subject.
Keywords: drug discovery, cancer, targeted therapies, immunotherapy, precision medicine, drug resistance, tumor heterogeneity
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
